TRex Bio Shares Trade Lower in Nasdaq Debut

MT newswire2026/10/09 16:42

12:42 PM EDT, 10/09/2026 (MT Newswires) -- TRex Bio (TRXB) stock fell over 3% to $13.55 on Friday midday after its Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million. The offering is expected to close on Oct. 13, the company said Thursday. Price: 13.55, Change: -0.45, Percent Change: -3.21

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54

Citi is bullish on the Indian stock market, expecting the Nifty Index to rise to 28,000 points by the end of 2027.

路透社•2026/11/09 04:06

Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure

FXStreet•2026/11/09 03:39